APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals in Nuclear Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Radiopharmaceuticals in Nuclear Medicine Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals in Nuclear Medicine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals in Nuclear Medicine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals in Nuclear Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals in Nuclear Medicine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals in Nuclear Medicine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Radiopharmaceuticals in Nuclear Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Radiopharmaceuticals in Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceuticals in Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceuticals in Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radiopharmaceuticals in Nuclear Medicine include Aurobindo Pharma, Bracco Imaging, Cardinal Health, Curium Pharma, GE Healthcare, Jubilant Pharma, Lantheus, Mundipharma and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Radiopharmaceuticals in Nuclear Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Radiopharmaceuticals in Nuclear Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiopharmaceuticals in Nuclear Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiopharmaceuticals in Nuclear Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Radiopharmaceuticals in Nuclear Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Radiopharmaceuticals in Nuclear Medicine Market by Company

Aurobindo Pharma

Bracco Imaging

Cardinal Health

Curium Pharma

GE Healthcare

Jubilant Pharma

Lantheus

Mundipharma

Novartis

SIEMENS

Bayer

Dongcheng

Eli Lilly

China Isotope & Radiation

Radiopharmaceuticals in Nuclear Medicine Segment by Type

Diagnostic Radiopharmaceuticals

Therapy Radiopharmaceuticals

Radiopharmaceuticals in Nuclear Medicine Segment by Application

Oncology

Cardiology

Other

Radiopharmaceuticals in Nuclear Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals in Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals in Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals in Nuclear Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals in Nuclear Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Radiopharmaceuticals in Nuclear Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diagnostic Radiopharmaceuticals Table 2. Major Company of Therapy Radiopharmaceuticals Table 3. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (K Units) Table 5. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Type (2021-2026) Table 8. Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2027-2032) & (K Units) Table 10. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Type (2027-2032) Table 13. Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (K Units) Table 15. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (K Units) Table 17. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Radiopharmaceuticals in Nuclear Medicine Industry Trends Table 25. Radiopharmaceuticals in Nuclear Medicine Industry Drivers Table 26. Radiopharmaceuticals in Nuclear Medicine Industry Opportunities and Challenges Table 27. Radiopharmaceuticals in Nuclear Medicine Industry Restraints Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2021-2026) Table 30. Global Radiopharmaceuticals in Nuclear Medicine Sales by Company (2021-2026) & (K Units) Table 31. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Company (2021-2026) Table 32. Global Radiopharmaceuticals in Nuclear Medicine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Radiopharmaceuticals in Nuclear Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Radiopharmaceuticals in Nuclear Medicine Major Company Production Sites and Headquarters Table 35. Global Radiopharmaceuticals in Nuclear Medicine Company, Product Type & Application Table 36. Global Radiopharmaceuticals in Nuclear Medicine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Radiopharmaceuticals in Nuclear Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2021-2026) & (K Units) Table 41. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Region (2021-2026) Table 44. Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2027-2032) & (K Units) Table 46. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Region (2027-2032) Table 49. Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (K Units) Table 52. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Application (2021-2026) Table 55. Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2027-2032) & (K Units) Table 57. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Application (2027-2032) Table 60. Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (K Units) Table 62. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (K Units) Table 64. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Aurobindo Pharma Company Information Table 72. Aurobindo Pharma Business Overview Table 73. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 75. Aurobindo Pharma Recent Development Table 76. Bracco Imaging Company Information Table 77. Bracco Imaging Business Overview Table 78. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 80. Bracco Imaging Recent Development Table 81. Cardinal Health Company Information Table 82. Cardinal Health Business Overview Table 83. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 85. Cardinal Health Recent Development Table 86. Curium Pharma Company Information Table 87. Curium Pharma Business Overview Table 88. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 90. Curium Pharma Recent Development Table 91. GE Healthcare Company Information Table 92. GE Healthcare Business Overview Table 93. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 95. GE Healthcare Recent Development Table 96. Jubilant Pharma Company Information Table 97. Jubilant Pharma Business Overview Table 98. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 100. Jubilant Pharma Recent Development Table 101. Lantheus Company Information Table 102. Lantheus Business Overview Table 103. Lantheus Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Lantheus Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 105. Lantheus Recent Development Table 106. Mundipharma Company Information Table 107. Mundipharma Business Overview Table 108. Mundipharma Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 110. Mundipharma Recent Development Table 111. Novartis Company Information Table 112. Novartis Business Overview Table 113. Novartis Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Novartis Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 115. Novartis Recent Development Table 116. SIEMENS Company Information Table 117. SIEMENS Business Overview Table 118. SIEMENS Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 120. SIEMENS Recent Development Table 121. Bayer Company Information Table 122. Bayer Business Overview Table 123. Bayer Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Bayer Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 125. Bayer Recent Development Table 126. Dongcheng Company Information Table 127. Dongcheng Business Overview Table 128. Dongcheng Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 130. Dongcheng Recent Development Table 131. Eli Lilly Company Information Table 132. Eli Lilly Business Overview Table 133. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 135. Eli Lilly Recent Development Table 136. China Isotope & Radiation Company Information Table 137. China Isotope & Radiation Business Overview Table 138. China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Product Portfolio Table 140. China Isotope & Radiation Recent Development Table 141. North America Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026) & (K Units) Table 143. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2021-2026) Table 144. North America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Radiopharmaceuticals in Nuclear Medicine Market Share by Country (2021-2026) Table 149. North America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Country (2027-2032) Table 151. Europe Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026) & (K Units) Table 153. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2021-2026) Table 154. Europe Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Country (2021-2026) Table 159. Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Country (2021-2026) Table 169. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Country (2027-2032) Table 171. Latin America Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026) & (K Units) Table 173. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2021-2026) Table 174. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Radiopharmaceuticals in Nuclear Medicine Market Share by Country (2021-2026) Table 179. Latin America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Country (2021-2026) Table 189. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Radiopharmaceuticals in Nuclear Medicine Distributors List Table 194. Radiopharmaceuticals in Nuclear Medicine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Radiopharmaceuticals in Nuclear Medicine Image Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceuticals in Nuclear Medicine Sales (2021-2032) & (K Units) Figure 5. Diagnostic Radiopharmaceuticals Image Figure 6. Global Diagnostic Radiopharmaceuticals Sales YoY Growth (2021-2032) & (K Units) Figure 7. Therapy Radiopharmaceuticals Image Figure 8. Global Therapy Radiopharmaceuticals Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Radiopharmaceuticals in Nuclear Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type 2025 VS 2032 Figure 11. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Type in 2025 Figure 12. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Type in 2025 Figure 13. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Radiopharmaceuticals in Nuclear Medicine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oncology Image Figure 24. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 25. Cardiology Image Figure 26. Global Cardiology Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Radiopharmaceuticals in Nuclear Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application 2025 VS 2032 Figure 31. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Application in 2025 Figure 32. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Application in 2025 Figure 33. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share in Value by Application in 2025 Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Radiopharmaceuticals in Nuclear Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Radiopharmaceuticals in Nuclear Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Radiopharmaceuticals in Nuclear Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Radiopharmaceuticals in Nuclear Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Radiopharmaceuticals in Nuclear Medicine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Radiopharmaceuticals in Nuclear Medicine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radiopharmaceuticals
  • Therapy Radiopharmaceuticals
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Aurobindo Pharma
  • Bracco Imaging
  • Cardinal Health
  • Curium Pharma
  • GE Healthcare
  • Jubilant Pharma
  • Lantheus
  • Mundipharma
  • Novartis
  • SIEMENS
  • Bayer
  • Dongcheng
  • Eli Lilly
  • China Isotope & Radiation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Radiopharmaceuticals in Nuclear Medicine Market by Type
  6. 1.3.1 Diagnostic Radiopharmaceuticals
  7. 1.3.2 Therapy Radiopharmaceuticals
  8. 1.4 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type
  9. 1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Radiopharmaceuticals in Nuclear Medicine Industry Trends
  2. 2.2 Radiopharmaceuticals in Nuclear Medicine Industry Drivers
  3. 2.3 Radiopharmaceuticals in Nuclear Medicine Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals in Nuclear Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Radiopharmaceuticals in Nuclear Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Radiopharmaceuticals in Nuclear Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Radiopharmaceuticals in Nuclear Medicine Price (2021-2026)
  4. 3.4 Global Radiopharmaceuticals in Nuclear Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceuticals in Nuclear Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Radiopharmaceuticals in Nuclear Medicine Company, Product Type & Application
  7. 3.7 Global Radiopharmaceuticals in Nuclear Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceuticals in Nuclear Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceuticals in Nuclear Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceuticals in Nuclear Medicine Tier 1, Tier 2, and Tier 3
4 Radiopharmaceuticals in Nuclear Medicine Regional Status and Outlook
  1. 4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Size by Region
  3. 4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Radiopharmaceuticals in Nuclear Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Radiopharmaceuticals in Nuclear Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Radiopharmaceuticals in Nuclear Medicine by Application
  1. 5.1 Radiopharmaceuticals in Nuclear Medicine Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application
  6. 5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aurobindo Pharma
  2. 6.1.1 Aurobindo Pharma Company Information
  3. 6.1.2 Aurobindo Pharma Business Overview
  4. 6.1.3 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  6. 6.1.5 Aurobindo Pharma Recent Developments
  7. 6.2 Bracco Imaging
  8. 6.2.1 Bracco Imaging Company Information
  9. 6.2.2 Bracco Imaging Business Overview
  10. 6.2.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  12. 6.2.5 Bracco Imaging Recent Developments
  13. 6.3 Cardinal Health
  14. 6.3.1 Cardinal Health Company Information
  15. 6.3.2 Cardinal Health Business Overview
  16. 6.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  18. 6.3.5 Cardinal Health Recent Developments
  19. 6.4 Curium Pharma
  20. 6.4.1 Curium Pharma Company Information
  21. 6.4.2 Curium Pharma Business Overview
  22. 6.4.3 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  24. 6.4.5 Curium Pharma Recent Developments
  25. 6.5 GE Healthcare
  26. 6.5.1 GE Healthcare Company Information
  27. 6.5.2 GE Healthcare Business Overview
  28. 6.5.3 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  30. 6.5.5 GE Healthcare Recent Developments
  31. 6.6 Jubilant Pharma
  32. 6.6.1 Jubilant Pharma Company Information
  33. 6.6.2 Jubilant Pharma Business Overview
  34. 6.6.3 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  36. 6.6.5 Jubilant Pharma Recent Developments
  37. 6.7 Lantheus
  38. 6.7.1 Lantheus Company Information
  39. 6.7.2 Lantheus Business Overview
  40. 6.7.3 Lantheus Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lantheus Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  42. 6.7.5 Lantheus Recent Developments
  43. 6.8 Mundipharma
  44. 6.8.1 Mundipharma Company Information
  45. 6.8.2 Mundipharma Business Overview
  46. 6.8.3 Mundipharma Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  48. 6.8.5 Mundipharma Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 SIEMENS
  56. 6.10.1 SIEMENS Company Information
  57. 6.10.2 SIEMENS Business Overview
  58. 6.10.3 SIEMENS Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  60. 6.10.5 SIEMENS Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bayer Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 Dongcheng
  68. 6.12.1 Dongcheng Company Information
  69. 6.12.2 Dongcheng Business Overview
  70. 6.12.3 Dongcheng Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  72. 6.12.5 Dongcheng Recent Developments
  73. 6.13 Eli Lilly
  74. 6.13.1 Eli Lilly Company Information
  75. 6.13.2 Eli Lilly Business Overview
  76. 6.13.3 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  78. 6.13.5 Eli Lilly Recent Developments
  79. 6.14 China Isotope & Radiation
  80. 6.14.1 China Isotope & Radiation Company Information
  81. 6.14.2 China Isotope & Radiation Business Overview
  82. 6.14.3 China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Product Portfolio
  84. 6.14.5 China Isotope & Radiation Recent Developments
7 North America by Country
  1. 7.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
  2. 7.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
  6. 7.2.1 North America Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
  2. 8.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
  6. 8.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Radiopharmaceuticals in Nuclear Medicine Sales by Country
  2. 10.1.1 South America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
  6. 10.2.1 South America Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Radiopharmaceuticals in Nuclear Medicine Value Chain Analysis
  2. 12.1.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Radiopharmaceuticals in Nuclear Medicine Production Mode & Process
  7. 12.2 Radiopharmaceuticals in Nuclear Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Radiopharmaceuticals in Nuclear Medicine Distributors
  10. 12.2.3 Radiopharmaceuticals in Nuclear Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst